Alzheimer disease ATN imaging biomarkers across type 2 diabetes mellitus stages in diverse populations
- Published on 06/03/2026
- Reading time: 1 min.
Malavika Pillai 1, Beau Ances 1, Sid E. O'Bryant 2, Karin L. Meeker 1
1 Washington University in St. Louis School of Medicine, St. Louis, MO USA
2 University of North Texas Health Science Center, Fort Worth, TX USA
Abstract
Background Type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimer disease (AD) and disproportionately impacts under‐represented groups including Mexican Americans/Hispanics (MAs) and African Americans/Blacks (AAs) compared to non‐Hispanic Whites (NHWs). However, it remains unclear how amyloid, tau, and neurodegeneration (AT(N)) AD imaging biomarkers and cognitive functioning differ across diabetic stages including non‐diabetes, pre‐diabetes,...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Neurology
Receive our newsletter to stay up to date with the latest news in Neurology
